News Conference News AATS 2023 Beware High-Risk TAVI in Patients With Low-Lying Coronaries Michael O'Riordan May 11, 2023
News Daily News TAVI Explantation Remains a Risky Proposition, Two New Studies Show Michael O'Riordan April 27, 2023
News Conference News ACC 2023 Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients Todd Neale March 05, 2023
News Conference News CRT 2023 New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR Yael L. Maxwell March 03, 2023
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Daily News Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration L.A. McKeown November 24, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2022 Shelley Wood May 02, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2022 Shelley Wood February 28, 2022
News Daily News SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS L.A. McKeown November 30, 2021
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021